RelucibaTM
Relugolix
Hormone Therapy (Oncology)
Indication:
RelucibaTM is indicated for the treatment of Advanced Prostate Cancer.
Dosage & Administration:
Recommended Dosage: A loading dose of 360 mg on the first day of treatment followed by 120 mg taken orally once daily, at approximately the same time each day.
Relugolix can be taken with or without food. Patients should be instructed to swallow tablets whole and not to crush or chew tablets.
Preparation:
RelucibaTM120 tablet: Each box contains 30 tablets in Alu-Alu blister pack.
